Clinical Trial Update: Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating TQ-B3234 capsules for symptomatic, non-surgical type 1 neurofibromatosis-associated plexiform neurofibromas is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• TQ-B3234

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Plexiform Neurofibroma | Phase 3 | Status: RECRUITING